EMA Authorised: Azacitidine Accord (azacitidine) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Azacitidine Accord, a generic azacitidine product, for myelodysplastic syndromes and certain leukemias (acute myeloid leukemia and chronic myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Azacitidine Accord (azacitidine)

Snippet

Status: Authorised. Therapeutic area: Myelodysplastic Syndromes;Leukemia, Myelomonocytic, Chronic;Leukemia, Myeloid, Acute. MAH: Accord Healthcare S.L.U.. Decision date: 07/10/2025